Chemokine and chemokine receptor gene expression in the mesenteric adipose tissue of KKAy mice

Cytokine

Volumn 46, Issue 2, 2009, Pages 160-165

  Lee, Han Sam ^a   Park, Jin Hee ^a   Kang, Ji Hye ^a   Kawada, Teruo ^b   Yu, Rina ^a   Han, In Seob ^a  

^a University of Ulsan   (South Korea)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Adipose tissue; Cytokines; Diabetes; Inflammation; Obesity

Indexed keywords

CCL25 CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR7; CXCL13 CHEMOKINE; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; RANTES; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC DISEASE; CHRONIC INFLAMMATION; CONTROLLED STUDY; DIABETES MELLITUS; GENE EXPRESSION; INFLAMMATION; INFLAMMATORY DISEASE; INTRAABDOMINAL FAT; LIPID DIET; LOW FAT DIET; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBCUTANEOUS FAT;

3T3-L1 CELLS; ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CHEMOKINES; DIET, FAT-RESTRICTED; DIETARY FATS; GENE EXPRESSION PROFILING; HUMANS; INFLAMMATION; MALE; MESENTERY; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; OBESITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, CHEMOKINE;

ANIMALIA; MUS;

EID: 65049088009     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.12.025     Document Type: Article

References (36)

1. Wellen K.E., and Hotamisligil G.S. Inflammation, stress, and diabetes. J Clin Invest 115 (2005) 1111-1119
2. Ozcan U., Cao Q., Yilmaz E., et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306 (2004) 457-461
3. Ozawa K., Miyazaki M., Matsuhisa M., et al. The endoplasmic reticulum chaperone improves insulin resistance in type 2 diabetes. Diabetes 54 (2005) 657-663
4. Neels J.G., and Olefsky J.M. Inflamed fat: what starts the fire?. J Clin Invest 116 (2006) 33-35
5. Lumeng C.N., Bodzin J.L., and Saltiel A.R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117 (2007) 175-184
6. Yu R., Kim C.S., Kwon B.S., et al. Mesenteric adipose tissue-derived monocyte chemoattractant protein-1 plays a crucial role in adipose tissue macrophage migration and activation in obese mice. Obesity (Silver Spring) 14 (2006) 1353-1362
7. Kim C.S., Park H.S., Kawada T., et al. Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters. Int J Obes (Lond) 30 (2006) 1347-1355
8. Bruun J.M., Lihn A.S., Pedersen S.B., et al. Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J Clin Endocrinol Metab 90 (2005) 2282-2289
9. Bigaard J., Frederiksen K., Tjonneland A., et al. Waist circumference and body composition in relation to all-cause mortality in middle-aged men and women. Int J Obes (Lond) 29 (2005) 778-784
10. Williams E.J., Haque S., Banks C., et al. Distribution of the interleukin-8 receptors, CXCR1 and CXCR2, in inflamed gut tissue. J Pathol 192 (2000) 533-539
11. Olsson J., Poles M., Spetz A.L., et al. Human immunodeficiency virus type 1 infection is associated with significant mucosal inflammation characterized by increased expression of CCR5, CXCR4, and beta-chemokines. J Infect Dis 182 (2000) 1625-1635
12. Sozzani S., Allavena P., Vecchi A., et al. Chemokines and dendritic cell traffic. J Clin Immunol 20 (2000) 151-160
13. Autschbach F., Funke B., Katzenmeier M., et al. Expression of chemokine receptors in normal and inflamed human intestine, tonsil, and liver-an immunohistochemical analysis with new monoclonal antibodies from the 8th international workshop and conference on human leucocyte differentiation antigens. Cell Immunol 236 (2005) 110-114
14. Izadpanah A., Dwinell M.B., Eckmann L., et al. Regulated MIP-3alpha/CCL20 production by human intestinal epithelium: mechanism for modulating mucosal immunity. Am J Physiol Gastrointest Liver Physiol 280 (2001) G710-719
15. Iwasaki A., and Kelsall B.L. Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3alpha, MIP-3beta, and secondary lymphoid organ chemokine. J Exp Med 191 (2000) 1381-1394
16. Greaves D.R., Wang W., Dairaghi D.J., et al. CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3[alpha] and is highly expressed in human dendritic cells. J Exp Med 186 (1997) 837-844
17. Cook D.N., Prosser D.M., Forster R., et al. CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity 12 (2000) 495-503
18. Varona R., Villares R., Carramolino L., et al. CCR6-deficient mice have impaired leukocyte homeostasis and altered contact hypersensitivity and delayed-type hypersensitivity responses. J Clin Invest 107 (2001) R37-45
19. Takahashi N., Kawada T., Yamamoto T., et al. Overexpression and ribozyme-mediated targeting of transcriptional coactivators CREB-binding protein and p300 revealed their indispensable roles in adipocyte differentiation through the regulation of peroxisome proliferator-activated receptor gamma. J Biol Chem 277 (2002) 16906-16912
20. Eisen M.B., Spellman P.T., Brown P.O., et al. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95 (1998) 14863-14868
21. Mysliwiec M., Balcerska A., Zorena K., et al. The role of vascular endothelial growth factor, tumor necrosis factor alpha and interleukin-6 in pathogenesis of diabetic retinopathy. Diabetes Res Clin Pract (2007)
22. Mansfield M.W. Increased plasma plasminogen activator inhibitor 1 in relatives of type 2 diabetic patients. Diabetes Care 23 (2000) 1035-1037
23. Gurlek A., Bayraktar M., and Kirazli S. Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels. Diabetes Care 23 (2000) 88-92
24. Festa A., D'Agostino Jr. R., Tracy R.P., et al. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 51 (2002) 1131-1137
25. Festa A., Williams K., Tracy R.P., et al. Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetes. Circulation 113 (2006) 1753-1759
26. Sartipy P., and Loskutoff D.J. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci USA 100 (2003) 7265-7270
27. Watanabe S., Yamakawa M., Hiroaki T., et al. Correlation of dendritic cell infiltration with active crypt inflammation in ulcerative colitis. Clin Immunol 122 (2007) 288-297
28. Dieu M.C., Vanbervliet B., Vicari A., et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 188 (1998) 373-386
29. Carramolino L., Kremer L., Goya I., et al. Down-regulation of the beta-chemokine receptor CCR6 in dendritic cells mediated by TNF-alpha and IL-4. J Leukoc Biol 66 (1999) 837-844
30. Hjelmstrom P. Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. J Leukoc Biol 69 (2001) 331-339
31. Timmer T.C., Baltus B., Vondenhoff M., et al. Inflammation and ectopic lymphoid structures in rheumatoid arthritis synovial tissues dissected by genomics technology: identification of the interleukin-7 signaling pathway in tissues with lymphoid neogenesis. Arthritis Rheum 56 (2007) 2492-2502
32. Pond C.M. Long-term changes in adipose tissue in human disease. Proc Nutr Soc 60 (2001) 365-374
33. Kobayashi H., Miura S., Nagata H., et al. In situ demonstration of dendritic cell migration from rat intestine to mesenteric lymph nodes: relationships to maturation and role of chemokines. J Leukoc Biol 75 (2004) 434-442
34. Marin V., Dander E., Biagi E., et al. Characterization of in vitro migratory properties of anti-CD19 chimeric receptor-redirected CIK cells for their potential use in B-ALL immunotherapy. Exp Hematol 34 (2006) 1219-1229
35. Matter C.M., and Handschin C. RANTES (regulated on activation, normal T cell expressed and secreted), inflammation, obesity, and the metabolic syndrome. Circulation 115 (2007) 946-948
36. Wu H., Ghosh S., Perrard X.D., et al. T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation 115 (2007) 1029-1038